<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0374630</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3841</journal-id>
<journal-id journal-id-type="nlm-ta">Gastroenterology</journal-id>
<journal-id journal-id-type="iso-abbrev">Gastroenterology</journal-id>
<journal-title-group>
<journal-title>Gastroenterology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0016-5085</issn>
<issn pub-type="epub">1528-0012</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31071306</article-id>
<article-id pub-id-type="pmc">6650329</article-id>
<article-id pub-id-type="doi">10.1053/j.gastro.2019.04.022</article-id>
<article-id pub-id-type="manuscript">NIHMS1527806</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Effects of Serotonin and Slow-release 5-HTP on Gastrointestinal Motility in a Mouse Model of Depression</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Israelyan</surname>
<given-names>Narek</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Colle</surname>
<given-names>Andrew Del</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Zhishan</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Park</surname>
<given-names>Yeji</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xing</surname>
<given-names>Albert</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jacobsen</surname>
<given-names>Jacob P.R.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luna</surname>
<given-names>Ruth Ann</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jensen</surname>
<given-names>Dane D.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Madra</surname>
<given-names>Moneek</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saurman</surname>
<given-names>Virginia</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rahim</surname>
<given-names>Ray</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Latorre</surname>
<given-names>Rocco</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Law</surname>
<given-names>Kimberly</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carson</surname>
<given-names>William</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bunnett</surname>
<given-names>Nigel W.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Caron</surname>
<given-names>Marc G.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Margolis</surname>
<given-names>Kara G.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Morgan Stanley Children’s Hospital, Department of Pediatrics, Columbia University Medical Center; New York, NY</aff>
<aff id="A2"><label>2</label>Institute of Human Nutrition, Columbia University Medical Center; New York, NY</aff>
<aff id="A3"><label>3</label>Department of Pathology and Cell Biology, Columbia University Medical Center; New York, NY</aff>
<aff id="A4"><label>4</label>Department of Cell Biology, Duke University School of Medicine; Durham, NC</aff>
<aff id="A5"><label>5</label>Texas Children’s Hospital Microbiome Center, Baylor College of Medicine; Houston, TX</aff>
<aff id="A6"><label>6</label>Departments of Surgery and Pharmacology, Columbia University Medical Center; New York, NY</aff>
<author-notes>
<corresp id="CR1"><bold>Corresponding author:</bold> Kara Gross Margolis, MD, Associate Professor of Pediatrics, Columbia University Medical Center, 622 West 168<sup>th</sup> Street, New York, NY 10025, Phone: 212-305-5903, <email>kjg2133@cumc.columbia.edu</email></corresp>
<fn fn-type="con" id="FN3">
<p id="P1"><bold>Author contributions:</bold> KGM, NI and ADC designed and conducted the studies, analyzed data, and wrote the manuscript. ADC, YP, AX, RAL, DDJ, MM, VS, RR, RL, KL, WC, and NWB conducted experiments and acquired data. MGC and JPRJ created and provided mice, conducted experiments, and analyzed data. All co-authors critically reviewed the manuscript.</p>
</fn>
<fn fn-type="COI-statement" id="FN2">
<p id="P49"><bold>Conflict of Interest Statement:</bold> JPRJ and MGC are inventors on US patents pertaining to the adjunct 5-HTP SR method-of-treatment, and hold equity in Evecxia Inc., a company founded to develop a 5-HTP SR drug for the management of serotonin related disorders. The remaining authors do not have any conflicts of interest (financial, professional or personal).</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>3</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>5</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<month>8</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>8</month>
<year>2020</year>
</pub-date>
<volume>157</volume>
<issue>2</issue>
<fpage>507</fpage>
<lpage>521.e4</lpage>
<!--elocation-id from pubmed: 10.1053/j.gastro.2019.04.022-->
<abstract id="ABS1">
<sec id="S1">
<title>Background &amp; Aims:</title>
<p id="P2">Mood disorders and constipation are often comorbid yet their shared etiologies have rarely been explored. The neurotransmitter serotonin (5-HT) regulates central nervous system and enteric nervous system (ENS) development and long-term functions, including gastrointestinal (GI) motility and mood. Defects in neuron production of 5-HT might therefore result in brain and intestinal dysfunction. Tryptophan hydroxylase 2 (TPH2) is the rate-limiting enzyme in 5-HT biosynthesis. A variant of <italic>TPH2</italic> that encodes the R441H substitution (TPH2-R441H) was identified in individuals with severe depression. We studied mice with an analogous mutation (TPH2-R439H), which results in a 60%–80% decrease in levels of 5-HT in central nervous system and behaviors associated with depression in humans. Feeding chow that contains 5-HTP slow release (5-HTP SR) to TPH2-R439H mice restores levels of 5-HT in the central nervous system and reduces depressive-like behaviors.</p>
</sec>
<sec id="S2">
<title>Methods:</title>
<p id="P3">We compared the effects of feeding chow, with or without 5-HTP SR, to mice with the TPH2-R439H mutation and without this mutation (control mice). Myenteric and submucosal plexuses were isolated from all 4 groups of mice and immunocytochemistry was used to quantify total enteric neurons, serotonergic neurons, and 5-HT–dependent subsets of neurons. We performed calcium imaging experiments to evaluate responses of enteric neurons to tryptamineevoked release of endogenous 5-HT. In live mice we measured total GI transit, gastric emptying, small intestinal transit, and propulsive colorectal motility. To measure colonic migrating motor complexes (CMMCs), we isolated colons and constructed spatiotemporal maps along the proximo-distal length to quantify the frequency, velocity, and length of CMMCs. We measured villus height, crypt perimeter, and relative densities of enterochromaffin and enteroendocrine cells in small intestinal tissue.</p>
</sec>
<sec id="S3">
<title>Results:</title>
<p id="P4">Levels of 5-HT were significantly lower in enteric neurons from TPH2-R439H mice than from control mice. TPH2-R439H mice had abnormalities in ENS development and ENS-mediated GI functions, including reduced motility and intestinal epithelial growth. Total GI transit and propulsive colorectal motility were slower in TPH2-R439H mice than controls and CMMCs were slower and less frequent. Villus height and crypt perimeter were significantly decreased in colon tissues from TPH2-R439H mice, compared with controls. Administration of 5-HTP SR to adult TPH2-R439H mice restored 5-HT to enteric neurons and reversed these abnormalities. Adult TPH2-R439H mice given oral 5-HTP SR had normalized numbers of enteric neurons, total GI transit, and colonic motility. Intestinal tissue from these mice had normal measures of CMMCs and enteric epithelial growth</p>
</sec>
<sec id="S4">
<title>Conclusions:</title>
<p id="P5">In studies of TPH2-R439H mice, we found evidence for reduced release of 5-HT from enteric neurons that results in defects in ENS development and GI motility. Our findings indicate that neuron production of 5-HT links constipation with mood dysfunction. Administration of 5-HTP SR to mice restored 5-HT to the ENS and normalized GI motility and growth of the enteric epithelium. 5-HTP SR might be used to treat patients with intestinal dysfunction associated with low levels of 5-HT.</p>
</sec>
</abstract>
<abstract abstract-type="graphical" id="ABS2">
<title>Graphical Abstract</title>
<p id="P6">
<graphic orientation="portrait" position="anchor" xlink:href="nihms-1527806-f0001.jpg"></graphic>
</p>
</abstract>
<kwd-group>
<kwd>gut–brain disease</kwd>
<kwd>mood disorders</kwd>
<kwd>GI dysfunction</kwd>
<kwd>CNS</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>